EANS-News: Balda AG: Supervisory Board approves further steps for an acquisition in the Medical business division

Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.

Bad Oeynhausen (euro adhoc) – 13 December 2010 – The Supervisory Board of the
Frankfurt Stock Exchange listed Balda AG, during its regular session on 10
December 2010 in Beijing, has confirmed the already initiated search for
acquisition opportunities for the planned strategic expansion of Balda Medical.

A further issue on the agenda was the continued sluggish business development
and the demanding conditions affecting the MobileCom business division.
Call-offs continue to be unsatisfactory. Competition is still very intense and
pressure on prices high. As already stated, the division is under constant
critical review by the Board of Directors.

No decision was taken on the issue of a potential disposal of Balda shares held
in TPK. The lock-up period for the first fifty per cent of the Balda stake in
TPK closes at the end of April 2011. A decision will be made in due time before
the end of the lock-up period. The Board of Directors and Supervisory Board will
strive to achieve a decision that is in the interests of Balda shareholders.

* * *

Company Profile Balda AG
The Balda Group develops and produces complete plastic assemblies, electronic
products and products for the medical industry. The customers of Balda are
leaders in business from the mobile, entertainment and electronic communications
as well as pharmaceutical and medical technology markets. The group has an
international position with product sites in China, Malaysia and Germany. A
subsidiary in the United States serves North American customers in product
design and development. As part of a shareholding in a leading manufacturer of
touch screens in China, Balda participates in the dynamic touch screen displays

* * *

This corporate news announcement includes ‘forward-looking statements’ which are
based on the current expectations of the management of Balda. They are subject
to risks and uncertainty because they relate to events and depend on
circumstances that will occur in the future, such as, for example, developments
in the mobile communications industry, changes in technology and the ability to
timely and successfully develop new products and various other factors. Balda
does not undertake any obligation to update publicly or revise forward-looking
statements except to the extent legally required. This corporate news
announcement is not an offer of securities for sale or a solicitation of an
offer to purchase securities in the United States or elsewhere. The shares in
Balda AG (the ‘Shares’) may not be offered or sold in the United States or to or
for the account or benefit of U.S. persons (as such term is defined in
Regulation S under the U.S. Securities Act of 1933, as amended (the ‘Securities
Act’) unless registered under the Securities Act or pursuant to an exemption
from such registration. The Shares have not been and will not be registered
under the Securities Act.

Further inquiry note:
Clas Röhl
Tel.: +49 (0) 5734 922-2728

company: Balda AG
Bergkirchener Str. 228
D-32549 Bad Oeynhausen
phone: +49 (0) 5734 9 22-0
FAX: +49 (0) 5734 922-2747
mail: info@balda.de
WWW: ¿U1http://www.balda.de¿U0
sector: Semiconductors & active components
ISIN: DE0005215107
indexes: CDAX, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Hamburg, Stuttgart, Düsseldorf, München
language: English